SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-13-006369
Filing Date
2013-11-14
Accepted
2013-11-14 09:05:03
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0913_tianyinpharma.htm 10-Q 476135
2 CERTIFICATION f10q0913ex31i_tianyinpharma.htm EX-31.1 14236
3 CERTIFICATION f10q0913ex31ii_tianyinpharma.htm EX-31.2 13851
4 CERTIFICATION f10q0913ex32i_tianyinpharma.htm EX-32.1 6190
5 CERTIFICATION f10q0913ex32ii_tianyinpharma.htm EX-32.2 6547
  Complete submission text file 0001213900-13-006369.txt   2288219

Data Files

Seq Description Document Type Size
6 tpi-20130930.xml EX-101.INS 230036
7 tpi-20130930.xsd EX-101.SCH 19882
8 tpi-20130930_cal.xml EX-101.CAL 42527
9 tpi-20130930_def.xml EX-101.DEF 26627
10 tpi-20130930_lab.xml EX-101.LAB 196357
11 tpi-20130930_pre.xml EX-101.PRE 116231
Mailing Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041
Business Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041 0086-028-86154737
TIANYIN PHARMACEUTICAL CO., INC. (Filer) CIK: 0001362718 (see all company filings)

IRS No.: 204857782 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-34189 | Film No.: 131217003
SIC: 2834 Pharmaceutical Preparations